QuickView for SLC25A47;jsessionid=08402281A476DE6DB62E8DD1E0EAA93A;jsessionid=9354337AA943AF1B678BC0D6166DDA0A;jsessionid=DF527527BCE52FA07C5F63EEBC9F8106;jsessionid=4470E2E78D3B0BF99A3A903628EFDA39;jsessionid=F7BCFB1D812AB0781BB10FBF48922E01;jsessionid=DA7B8D6FC3A4B643DA6B668B4D1D3736;jsessionid=2AB9069160CEBA1CCC77F347A81C057A;jsessionid=15AE8031E087783C03B323B7B6749BF5;jsessionid=77AFE17D32A764B6BCBA564EE75B367B;jsessionid=05299D1D851E3F16D4AA3145EB62BC51;jsessionid=A4E483D2FCEE41B79030BE406F4D6307 (gene)

1. Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis.
2. HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by d…
3. Uncoupling protein and nonalcoholic fatty liver disease.
4. Cloning and identification of hepatocellular carcinoma down-regulated mitochondrial carrier protein,…
5. Tryptophanyl-tRNA synthetase gene polymorphisms and risk of incident myocardial infarction.

There were no clinical trials for SLC25A47;jsessionid=08402281A476DE6DB62E8DD1E0EAA93A;jsessionid=9354337AA943AF1B678BC0D6166DDA0A;jsessionid=DF527527BCE52FA07C5F63EEBC9F8106;jsessionid=4470E2E78D3B0BF99A3A903628EFDA39;jsessionid=F7BCFB1D812AB0781BB10FBF48922E01;jsessionid=DA7B8D6FC3A4B643DA6B668B4D1D3736;jsessionid=2AB9069160CEBA1CCC77F347A81C057A;jsessionid=15AE8031E087783C03B323B7B6749BF5;jsessionid=77AFE17D32A764B6BCBA564EE75B367B;jsessionid=05299D1D851E3F16D4AA3145EB62BC51;jsessionid=A4E483D2FCEE41B79030BE406F4D6307